z-logo
open-access-imgOpen Access
Brief report: Cause of death among people discharged from infective endocarditis related hospitalization—West Virginia, 2016–2019
Author(s) -
Dai Zheng,
Smith Gordon S.,
Hendricks Brian,
Bhandari Ruchi
Publication year - 2022
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.23812
Subject(s) - medicine , polysubstance dependence , medicaid , opioid use disorder , cause of death , infective endocarditis , endocarditis , emergency medicine , demography , pediatrics , psychiatry , substance abuse , disease , health care , opioid , receptor , sociology , economics , economic growth
Background and Objectives Compare proportion of all‐cause and cause‐specific mortality among West Virginia Medicaid enrollees who were discharged from infective endocarditis (IE) hospitalization with and without opioid use disorder (OUD) diagnosis. Methods The proportions of cause‐specific deaths among those who were discharged from IE‐related hospitalizations were compared by OUD diagnosis. Results The top three underlying causes of death discharged from IE hospitalization were accidental drug poisoning, mental and behavioral disorders due to polysubstance use, and cardiovascular diseases. Of the total deaths occurring among patients discharged after IE‐related hospitalization, the proportion has increased seven times from 2016 to 2019 among the OUD deaths while it doubled among the non‐OUD deaths. Discussion and Conclusions Of the total deaths occurring among patients discharged after IE‐related hospitalization, the increase is higher in those with OUD diagnosis. OUD is becoming a significantly negative impactor on the survival outcome among IE patients. It is of growing importance to deliver medication for OUD treatment and harm reduction efforts to IE patients in a timely manner, especially as the COVID‐19 pandemic persists.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here